The “gene patent” dichotomy between the US and Australia
The recent Meat & Livestock Australia Limited v Cargill, Inc (MLA) Federal Court decision has brought the significant differences that exist between Australian and US “gene patent” practice into sharp focus. These differences...
The recent Meat & Livestock Australia Limited v Cargill, Inc (MLA) Federal Court decision has brought the significant differences that exist between Australian...
Read More
Australia remains a gene-patent friendly jurisdiction
When the Australian High Court ruled against the patentability of isolated naturally occurring genes in the Myriad decision, a number of commentators believed that the decision would ultimately invalidate...
When the Australian High Court ruled against the patentability of isolated naturally occurring genes in the Myriad decision, a...
Read More
Pfizer succeeds in Full Federal Court appeal and will now receive preliminary discovery regarding possible infringement of biological medicine process patents
We previously reported on the 21 March 2017 decision of Burley J of the Federal Court of Australia in Pfizer Ireland Pharmaceuticals v Samsung Bioepis AU Pty Ltd  FCA 285, in which...
We previously reported on the 21 March 2017 decision of Burley J of the Federal Court of Australia in Pfizer Ireland Pharmaceuticals...
Read More
The Patent Office provides clarity regarding enablement of polypeptide claims
Australia has relatively recently implemented support laws that require a specification to provide sufficient information to enable the skilled person to perform an invention over the entire scope of the claims...
Australia has relatively recently implemented support laws that require a specification to provide sufficient information to enable the skilled person to...
Read More
Australia Update: Swiss style claims and patent term extension
Under Australian patent law, the term of a pharmaceutical patent may be extended if certain criteria are met. In this regard, a patent term extension (PTE) of up to...
Under Australian patent law, the term of a pharmaceutical patent may be extended if certain criteria are met. In...
Read More
Patent Term Extensions in Australia: under pressure but safe for now
Government responds to the Productivity Commission Report and the Courts find “Swiss-style” claims not sufficient for a PTE The Australian Government, in its highly anticipated response to the Productivity Commission’s...
Government responds to the Productivity Commission Report and the Courts find “Swiss-style” claims not sufficient for a PTE The Australian...
Read More
Protection of Second and Subsequent Medical Use in Singapore
In Singapore, second and subsequent medical use of a known substance has traditionally been claimed as Swiss-style claims which take the form of “Use of compound X in the...
In Singapore, second and subsequent medical use of a known substance has traditionally been claimed as Swiss-style claims which...
Read More